RBC Capital raised the firm’s price target on Diversified Healthcare Trust to $3 from $2 and keeps an Underperform rating on the shares. The company is working on a few positive debt refinancings that should improve the liquidity position and reduce debt costs, but the firm remains concerned that its adjusted FFO remains negative and will likely stay negative in 2025 and possibly in 2026, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHC: